The Top 5 Myths About eCOAs In 2025

Think you know about eCOAs? You might just be scratching the surface. Join R&D experts as they debunk the top five eCOA myths holding clinical teams back in 2025 — so you can make smarter, faster decisions that drive better trial outcomes.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/myths-about-eCOAs

Event overview:

Electronic Clinical Outcome Assessments (eCOAs) have come a long way—but outdated misconceptions about their adoption and use prevent clinical teams from unlocking their potential. With evolving regulations, fierce competition, and growing demands for greater efficiency, can you afford to let the myths hold you back?

A recent study by the Partnership for Advancing Clinical Trials (PACT) revealed that eCOAs are the most deployed decentralized clinical trial (DCT) solution, used in 80% of the 70 studies they analyzed—but not all eCOA solutions are created equally.

Whether you're exploring eCOA for the first time or looking to maximize its value across your R&D portfolio, this session is designed for you.

Join leading clinical experts as they discuss and debunk the top 5 myths about eCOA in 2025, separating fact from fiction to help clinical operations, procurement, and data management teams make smarter, faster decisions.
You’ll walk away with:

• The truth about eCOA costs and implementation speed
• How to maximize adherence while reducing site and patient burden
• Why modern eCOA solutions are easier to integrate than ever
• Real-world examples of sponsors and CROs getting eCOA right

Key Learning Objectives

• eCOA Myths, Debunked - Get the truth about eCOAs across patient experience, data quality, cost-efficiency, and strategy.
• Data-Backed Insights - Explore the latest research and real-world evidence on eCOA deployment, cutting through the noise with hard facts.
• Optimized Vendor Decisions - Learn the key criteria for evaluating eCOA providers so you can choose a solution that truly meets your trial’s needs.

Who Should Attend

Segments:

• Large pharma and biotech
• Midmarket pharma and biotech
• CROs

Professionals in:

• Clinical operations/development/research/R&D
• eCOA/ePRO leads
• Therapeutic area leads
• Strategy/growth
• Data management/processing/analysis/science/collection
• Procurement
• Trial innovation/management/optimization
• Digital innovation/decentralized trials/clinical innovation
• Digital end points/digital health
• Real-world evidence/data
• Clinical IT/systems
• Patient outcomes/solutions

Speakers:

Cindy Howry, M.S.
VP, eCOA Science
Medable

Cindy Howry, M.S., is a nationally recognized thought leader in electronic clinical outcome assessments (eCOA) and digital physiological measures. With a career spanning over 35 years in management and leadership — including 21 years in clinical research — she has been at the forefront of driving innovation that enhances patient engagement and delivers higher-quality clinical data in real-time.

As vice president of eCOA Science at Medable, Howry leverages her deep expertise to advance eCOA solutions that improve trial efficiency and scientific integrity. Previously, she served as CEO of AssisTek, where she led the development of eSource solutions for health care and R&D. She also held the elected position of vice director for the ePRO Consortium at C-PATH for three terms, collaborating with industry leaders to refine and standardize electronic data capture methods for PRO end point assessments.

Howry’s extensive experience includes leadership roles in product strategy, innovation, and client services at YPrime, Bracket Global, and Arrowhead Electronic Healthcare. Beyond her contributions to clinical development, she spent 13 years as a professor of computer science at Collin College. She holds a B.S. in counselor education and an M.S. in computer science from the University of North Texas.

Mark Wade
Global Practice Leader Life Sciences, COA SME
TransPerfect

Mark P. Wade holds the position of Global Practice Leader at TransPerfect Life Sciences, the largest language translation company globally, where he is the resident SME for all clinical trial processes and translation. Mr. Wade’s 20 years in life sciences include International Regional Director for EMEA at Ethicon and Ethicon Endo Surgery, Johnson & Johnson companies (NYSE: JNJ). For almost 10 years, Mr. Wade was the Global Practice Leader at another global language translation company. He is a published expert in eCOAs, including two ebooks, clinical posters and numerous articles in trade journals. He has significant experience and has published in clinical services, patient recruitment, and site selection.

Mr. Wade has chaired, presented, and published posters at DIA Annual Symposia and numerous other internationally recognized conferences. He is an active committee member of the C-Path eCOA Consortium, ISOQOL Translation & Cultural Adaptation (TCA) Special Interest Group (SIG), ISPOR TCA SIG, and DIA Endpoint Study Group.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/myths-about-eCOAs